Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | ATM | Q13315 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CFTR | P13569 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7034926 | 0.92 | MAPT (0.74) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL17145917 | 0.91 | MAPT (0.67) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL8128228 | 0.91 | KDM4E (0.68) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL30294456 | 0.91 | MAPT (0.67) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL13224505 | 0.90 | MAPT (0.89) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL28660739 | 0.89 | MAPT (0.65) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL15119809 | 0.89 | MAPT (0.65) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL2314122 | 0.89 | HSD17B10 (0.68) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL31914 | 0.88 | MAPT (1.00) | MAPTALOX15KDM4EPOLBATM | |
| SCHEMBL9409083 | 0.86 | MAPT (0.61) | MAPTALOX15KDM4EPOLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123383-A1 | ORGANIC COMPOUND AND DISPLAY PANEL | 武汉华星光电半导体显示技术有限公司 | 2025-06-19 | — | — | WO | disclosed |
| CN-119462691-A | Quinoline acridine-5, 9-diketone MR-TADF red light luminescent material and preparation method and application thereof | 常州大学 | 2025-02-18 | — | — | CN | disclosed |
| US-11859131-B2 | Electrochromic compound, electrochromic composition, and electrochromic element | RICOH COMPANY, LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| US-11370963-B2 | Electrochromic compound, electrochromic composition, and electrochromic element | RICOH COMPANY, LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20210198564-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC ELEMENT | RICOH COMPANY, LTD. (JP) | 2021-07-01 | — | — | US | disclosed |
| US-10090114-B2 | Triphenylamine derivatives and photovoltaic device including the same | Pusan National University Industry—University Cooperation Foundation (KR) | 2018-10-02 | — | — | US | disclosed |
| US-20170194103-A1 | NOVEL TRIPHENYLAMINE DERIVATIVES AND PHOTOVOLTAIC DEVICE INCLUDING THE SAME | KOREA INSTITUTE OF MATERIALS SCIENCE (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194103-A1 | NOVEL TRIPHENYLAMINE DERIVATIVES AND PHOTOVOLTAIC DEVICE INCLUDING THE SAME | KOREA INSTITUTE OF MATERIALS SCIENCE (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194103-A1 | NOVEL TRIPHENYLAMINE DERIVATIVES AND PHOTOVOLTAIC DEVICE INCLUDING THE SAME | KOREA INSTITUTE OF MATERIALS SCIENCE (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194103-A1 | NOVEL TRIPHENYLAMINE DERIVATIVES AND PHOTOVOLTAIC DEVICE INCLUDING THE SAME | TRMT1, ICMT, TRDMT1 | MAPT 879/4885ALOX15 3128/4885KDM4E 2197/4885 |
| US-10090114-B2 | Triphenylamine derivatives and photovoltaic device including the same | TRMT1, TRDMT1, ICMT | MAPT 728/4885ALOX15 3103/4885KDM4E 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.